Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @AlvinLuk_Health
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @AlvinLuk_Health
-
Cell Research published anti-nCoV drug screening report with cell-based assay today.
#Chloroquine is used in RA and in#malaria can also suppress nCoV as#remdesivir I checked EC50 to kill the#virus is 1130nM. I think 600mgQDx14days may#cure#2019_nCov infection! Am I crazy
?pic.twitter.com/wwTNLJs9iu
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We’ve expedited to develop appropriate laboratory testing of
#Remdesivir (瑞德西韦) against#2019nCoV and initiate a#randomized, controlled#clinicaltrial of 270 patients expecting to begin tonight (03Feb) in#China while our effort continues to develop#vaccines for#2019nCoVpic.twitter.com/B968obroA4
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Honor to present at
#ESMO2019 on#trastuzumab#biosimilar HLX02 which met primary endpoint with no clinically meaningful difference from#Herceptin (80K€/pt). Results were filed to China#NMPA &#EMA for approvals. Beyond cost benefits, use of HLX02 may provide patient benefit!pic.twitter.com/jYOSWjWB94
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
I have done IPO in US only and 复宏汉霖 | Henlius IPO in HKG has provided me valuable experience dealing with analysts, asset management and investment portfolio management in China, Hong Kong, USA and UK! https://lnkd.in/f3wpkeS
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Alvin Luk proslijedio/la je Tweet
Please join me,
@stevenholtzman,@jmaxlevin &@JMaraganore and many other#biomedical leaders in signing this letter on the threat to biomedical progress if we do not guard against generalized suspicion of Chinese scientists.#biotech#sciencehttps://bioengineeringcommunity.nature.com/users/293401-jeremy-levin/posts/52558-building-xbrane-biopharma …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
7 Argentinians (aged 14-21 years) with Leber
#hereditary#opticneuropathy (#LHON) went to#China to be part of the#AAV2-ND4#genetherapy clinical trial for their#blindness. Time to think about getting gene therapy treatment in China?#affordable#cure https://lnkd.in/f_azupgHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
“
#manufacturing will make or break each investment opportunity in the#genetherapy space — proving even more important than successful#clinicaltrial results.”https://lnkd.in/fKeniSsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The
#PD1 pathway has an important role in inhibiting the function of virus-specific CD8+#Tcells in chronic#HBV,#HCV, and#HIV infection. The PD-1 expression level on CD4+ T cells was elevated in chronic HBV-infected patients but…https://lnkd.in/fPKbHi9 https://lnkd.in/fiZvAbYHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Waiting for the sunset while sipping on cocktails...... @ Lisbon, Portugal https://www.instagram.com/p/BzOQa4vByU3f4h_L0H7gQiAHvQekAfWAxUAyys0/?igshid=1uawma53foslq …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
First night in
#lisbon and we decided to go to#boubouslisboa /#boubouslisbon . The cocktails are the killers! You will go to heaven by trying their#lambshoulder and a bottle… https://www.instagram.com/p/BzB6PA8hjYUFp_EOK8_ml1Jdl-VHLY_uBs80dY0/?igshid=7zbu0pgem2e9 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
International Society on Thrombosis and Haemostasis (ISTH)
#ISTH2019 oral sessions#hemophilia#genetherapy uniQure on#hemophiliaB , Sangamo Therapeutics, Inc. on#hemophiliaA and Spark Therapeutics, Inc. on#HRQoL.https://lnkd.in/eHEAa4BHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Thanks to the advances in manufacturing technology and gene sequencing,
#affordable#biologics and cell/#genetherapy have made it possible.#Antibody therapy, immunotherapy, CAR-T and gene therapy can be expensive and none of the current approved therapy…https://lnkd.in/ff_egT8Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thanks to advances in manufacturing technology and gene sequencing, affordable biologics and cell/
#genetherapy have made it possible. Antibody therapy, immunotherapy, CAR-T and gene therapy can be expensive and none of the current approved therapy is tar…https://lnkd.in/fpR3f2mHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
It’s in great honor to review potential
#genetherapy products from CHOP - a goal to allow effective therapy be beneficial not only US and EU but rest of the world!#affordable#sustainable#genetherapyhttps://lnkd.in/eDA9ZPEHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Gene therapy has the potential to reimagine the future of rare and devastating diseases. The Institute for Clinical and Economic Review agreed for $2,100,000 USD on
#Zolgensma to treat a fatal SMA disease while FDA approved#LUXTUR…https://lnkd.in/fV83Hdf https://lnkd.in/fmYmr-yHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
China NMPA approved Shanghai
#Henlius 1st#biosimilar. Roche recently took a 40% price cut on reference product for NRDL reimbursement in 2017. Henlius is also developing#trastuzumab#bevacizumab#adalimumab and other biosimilars.https://www.biocentury.com/bc-extra/company-news/2019-02-25/china-approves-first-biosimilar-shanghai-henlius%E2%80%99-hlx01 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Alvin Luk proslijedio/la je Tweet
Some biosimilars are just as good as some pricey biologics http://bit.ly/2UHGWaD via
@DrugPatentWatch#pharmapic.twitter.com/zyQcnl2Mzd
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.